Literature DB >> 20967799

An active intracellular device to prevent lethal disease outcomes in virus-infected bacterial cells.

Sangram Bagh1, Mahuya Mandal, Jordan Ang, David R McMillen.   

Abstract

Synthetic biology includes an effort to logically control cellular behavior. One long-term goal is to implement medical interventions inside living cells, creating intracellular "disease fighters"; one may imagine a system that detects viral infection and responds to halt the spread of the virus. Here, we explore a system designed to display some of the qualitative features that such disease prevention systems should have, while not claiming that the system itself has any medical application. An intracellular disease prevention mechanism should: lie dormant in the absence of the disease state; detect the onset of a lethal disease pathway; respond to halt or mitigate the disease's effects; and be subject to external deactivation when required. We have created a device that displays these properties, in the highly simplified case of a bacterial viral disease. Our system detects the onset of the lytic phase of bacteriophage lambda in Escherichia coli, responds by preventing this lethal pathway from being followed, and is deactivated by a temperature shift. We have formulated a mathematical model of the engineered system, using parameters obtained from the literature and by local experimental measurement, and shown that the model captures the essential experimental behavior of the system in most parameter regimes.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20967799     DOI: 10.1002/bit.22969

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  1 in total

1.  A frame-shifted gene, which rescued its function by non-natural start codons and its application in constructing synthetic gene circuits.

Authors:  Kathakali Sarkar; Sayak Mukhopadhyay; Deepro Bonnerjee; Rajkamal Srivastava; Sangram Bagh
Journal:  J Biol Eng       Date:  2019-03-01       Impact factor: 4.355

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.